Shanghai Fosun Pharmaceutical (02196) repurchased 1.2 million shares for HK$19.44 million on October 29.
Shanghai Fosun Pharmaceutical (02196) announced that on October 29, 2026, it repurchased 1.2 million shares for HK$19.44 million.
Shanghai Fosun Pharmaceutical (02196) announced that on October 29, 2026, it repurchased 1.2 million shares for HK$19.44 million.
Related Articles
BASECARE-B (02170) repurchased 35,000 shares on October 29 for approximately HK$48,400.
CH MODERN D (01117) subsidiary CH MODERN D (Group) reported net profit attributable to shareholders of RMB137 million for the first three quarters.
NANHUA FUTURES (02691) repurchased 52,500 shares on October 29 for HK$292,300.
BASECARE-B (02170) repurchased 35,000 shares on October 29 for approximately HK$48,400.
CH MODERN D (01117) subsidiary CH MODERN D (Group) reported net profit attributable to shareholders of RMB137 million for the first three quarters.
NANHUA FUTURES (02691) repurchased 52,500 shares on October 29 for HK$292,300.
